Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

Presentation CCVVC 2016

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

Presenter: Tyrone Collins

June 15, 2016

Presentation CCVVC 2016

The Role of Conventional, Covered, and Interwoven Stents in Complex Femero- Popliteal Lesions

Presenter: Chris Metzger

June 15, 2016

Presentation CICT 2015

Drug Eluting Femoral Stents Where does it fit in my practice?

Presenter: Yazan Khatib

July 31, 2015

Presentation CCVVC 2015

Covered Stents in Femoropopliteal Disease

Presenter: Subhash Banerjee

June 18, 2015

Presentation ARCH 2015

Below the Knee Stenting

Presenter: George S. Chrysant

April 10, 2015

Presentation TCT 2014

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Eric J. Dippel

September 16, 2014

Presentation TCT 2014

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

Presenter: Kenneth Rosenfield, Thomas Zeller, Raghu Kolluri

September 15, 2014

Presentation TCT 2014

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Presenter: Lawrence A. Garcia, Richard M. Green, Douglas E. Drachman, Takao Ohki, MD

September 14, 2014

Presentation TCT 2014

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte

September 14, 2014

Presentation

SMART Nitinol Self-expanding Stent in the Treatment of Obstructive Superficial Femoral Artery Disease

Presenter: Michael R. Jaff

January 20, 2014

Presentation

Stent Placement vs. Balloon Angioplasty for Obstructive Lesions in the Popliteal Artery

Presenter: Aljoscha Rastan

June 05, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

Presentation TCT 2013

The Multilayer Flow Modulator Stent For The Treatment Of Popliteal Aneurysm.

Presenter: Michel Henry, Amira BENJELLOUN, Isabelle Henry, Antonios Polydorou

January 31, 2013

Presentation TCT 2013

Evaluation of Long-term Vascular Responses to Fluorocopolymer coated Self-Expanding low-dose Paclitaxel-eluting Stent in Porcine Ilio-femoral Model

Presenter: Dongming Hou, Barbara Huibregtse, William Stoffregen, Gordon Kocur, Cory Hitzman, Elizabeth Stejskal, John Heil, Keith Dawkins

January 31, 2013

Presentation TCT 2013

A New Concept Of Stent: The Multilayer Flow Modulator. First Human Study In Peripheral And Visceral Aneurysms

Presenter: Michel Henry, Amira BENJELLOUN, Isabelle Henry, Antonios Polydorou

January 31, 2013

Presentation TCT 2013

Below-Knee Drug Eluting Stents Have Improved Patency, and Symptoms Compared to Bare Metal Stents: a meta-analysis

Presenter: Alexandre Benjo, Francisco Macedo, Emad Aziz, Francisco Nascimento, Fahad Javed, Eyal Herzog, Tyrone Collins, Christopher White

January 31, 2013

Presentation

Treatment of Complex Popliteal Artery Disease with a New Self-Expanding Interwoven Nitinol Stent

Presenter: Dierk Scheinert

January 24, 2013

Presentation TCT 2012

A Prospective, Randomized Trial of Nitinol Stents vs. Balloon Angioplasty in Obstructive Popliteal Lesions

Presenter: Thomas Zeller

October 24, 2012

Advertisement

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials

The Role of Conventional, Covered, and Interwoven Stents in Complex Femero- Popliteal Lesions

Drug Eluting Femoral Stents Where does it fit in my practice?

Covered Stents in Femoropopliteal Disease

Below the Knee Stenting

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

DCB Use in the Real World I: In-Stent Restenosis Insights From the FAIR Trial

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

SMART Nitinol Self-expanding Stent in the Treatment of Obstructive Superficial Femoral Artery Disease

Stent Placement vs. Balloon Angioplasty for Obstructive Lesions in the Popliteal Artery

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

The Multilayer Flow Modulator Stent For The Treatment Of Popliteal Aneurysm.

Evaluation of Long-term Vascular Responses to Fluorocopolymer coated Self-Expanding low-dose Paclitaxel-eluting Stent in Porcine Ilio-femoral Model

A New Concept Of Stent: The Multilayer Flow Modulator. First Human Study In Peripheral And Visceral Aneurysms

Below-Knee Drug Eluting Stents Have Improved Patency, and Symptoms Compared to Bare Metal Stents: a meta-analysis

Treatment of Complex Popliteal Artery Disease with a New Self-Expanding Interwoven Nitinol Stent

A Prospective, Randomized Trial of Nitinol Stents vs. Balloon Angioplasty in Obstructive Popliteal Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content